We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Crowdfunding Opportunities by Envestors


Metal matrix composite components and materials, primarily comprised of aluminium for use in the engineering and manufacturing industries. Alvant specialise in designing, developing and producing the composite for well-known clients such as Ford and Safran. In the last financial year, Alvant achieved a turnover of almost £617k and has invested more than £10m towards manufacturing and testing their own product. Alvant is now raising funds to distribute their components to a wider market and expand the number of commercial applications that would benefit from their materials.
investment: £1,209,836 target: £2,500,000
status: Active 4 days
to go
More Information
48%
The Odd Flower Manufacturing and Retail EIS
The Odd Flower is a marketing brand and technology disrupting the ‘traditional’ luxury flower model. The brand has avoided the expensive high street shop and operates via an online offering supported by a flower fulfilment supplier and centralised sourcing. The Odd Flower has produced over 600 customers and delivered 1,500 boxes, at an average of 2.5 orders per customer. Furthermore, this company has high-profiling companies and people as its customers like Natasha Archer and HRH Duchess of Cambridge. Additionally, it has also enjoyed enormous success in the media and has been featured in the Evening Standard, Sunday Times Style, and graced the covers of Homes & Gardens to name but a few.
investment: £50,165 target: £550,000
status: Active 68 days
to go
More Information
9%
Cambridge Medical Technologies Limited Medical EIS
Cambridge Medical Technologies Limited (CMT) is a medical technology company which operates in the UK and the US. The company specialises in portable and wearable biosensors for medical applications. CMT’s products and subsystems provide clinical accuracy and real-time monitoring of certain blood biomarkers without the need for invasive blood tests. With its range of tech-enhanced medical products, CMT is thriving in the blood testing market, which is expected to reach $62.9bn by 2024.
investment: £1,750,160 target: £5,000,000
status: Active 18 days
to go
More Information
35%
Sprint Enterprise Technology Professional, Financial and Business EIS
Sprint Enterprise Technology was shaped in 2010 by a team of exceedingly experienced monetary consultants and business visionaries. They personally comprehend client requirements to render powerful solutions that surpass the necessities of RDR and give more financially savvy processes. Its product “Fastrak” is a SaaS-based client reporting and data aggregation platform designed to cater diverse needs of Wealth Management industry.
investment: £425,056 target: £850,000
status: Active 4 days
to go
More Information
50%
Nova Pangaea Technologies Manufacturing and Retail EIS
Nova Pangaea Technologies offers Refnova®, a technology that uses fractionation to convert waste into biomass. This company's independent commercial and technical due diligences confirm notable advantages when compared to other known biomass conversion technologies, especially, in terms of product quality and range. It has a 20 kilo/hour pilot plant commissioned in 2016 and has achieved exciting results in line with expectations, enabling it to design a huge pre-commercial demonstration plant. Nova Pangaea Technologies has already worked with a variety of potential implementers both locally and internationally. Currently, it is embracing a broad range of feedstocks, with a prospect of enabling implementation of commercial-scale designs that is to begin in early 2020.
investment: £485,000 target: £3,000,000
status: Active 20 days
to go
More Information
16%
Goodbox Technology EIS
GoodBox builds technology to connect/join donors with causes. It allows charities to raise their fundraising perspective through its award-winning series of contactless technology. GoodBox has already engaged over 40 museums (including 5 of the top 7), 180 charities 11 hospitals and many high street brands. The company is now ready to change the UK charity sector (worth  £9.7bn) with the right product at the right time. Goodbox's data shows a rise of 20% in total funds raised by charities. The company is planning to receive income from its mobile applications and web platforms, and it is making more products, both physical and platform based.
investment: £1,247,000 target: £5,000,000
status: Active 9 days
to go
More Information
25%
Thyngs Ltd. Technology EIS
Thyngs harness the technology to transform any physical object into an instant point of sale. This means that the consumers can buy anything without the need to find a tool, and sellers can sell anything without a physical point of sale. It is a simple and secure mobile solution that does not require a dedicated application or payment terminals. The Thyngs platform has been designed to take all the complexity around proximity technology, mobile operating systems, and payment mechanisms that make it simpler for the buyers and the sellers. Thyngs has made great relationships with businesses like Apple, Stripe, Paypal, and Wasabi. By the end of this financial year, the company is projecting to achieve a turnover of £1.3m. With the proceeds, it is seeking to invest in sales & marketing and gain high-profile flagship customers.
investment: £235,500 target: £1,000,000
status: Active 4 days
to go
More Information
24%
THE FACE RECOGNITION COMPANY Technology EIS
The Face Recognition Company (FRC) produces 90%+ accurate face recognition solution. In 2016, the company came up with the objective to develop the most accurate and cost-effective facial recognition solution. This technology is suitable for commercial applications or crime and other security uses. Additionally, the FRC's go-to-market strategy incorporates working through large integrators/partners/approved installers, eight of which are ready to promote and install its product to their own customer base. The FRC team has technically developed this solution by combining 100 years of experience in facial recognition. In June 2018, FRC had filed for two patents: first, ‘Recognition of 3D Objects’ and second, 'Method of and System for Recognising a Human Face’. Where suitable, FRC has also set-up an EIS tax relief.
investment: £156,800 target: £333,200
status: Active 35 days
to go
More Information
47%
vzInternet Limited Technology EIS
A cyber-defence system preventing criminals accessing secure information from internet-enabled businesses. vzInternet Limited have developed Assayer, a cloaking tool that works differently to traditional cybersecurity systems. Assayer aims to tackle criminal behaviour by removing the time they have to exploit an organisation, rather than current methods that only add more layers for criminals to break through. vzInternet Limited is in the process of creating three version of their Assayer range, targeted for specific needs. Assayer Freedom is the initial offering that will prevent criminals from using stolen information and biometric data to access private material. Assayer Trust aims to tackle malware designed to convince customers to provide personal information and Assayer Veto is being created to protect businesses from internal attacks by employees and third-party contractors.
investment: £60,000 target: £500,000
status: Funded 4 days
to go
More Information
12%
Living With Medical EIS
A medical condition management platform allowing clinicians to create their own app to improve a patient's health whilst reducing costs. Living With develops smart apps specific to a person's condition, they currently have 3 products with another in the development stage. Their primary app, Squeezy, is the top paid medical app in the UK that helps patients with their pelvic floor exercises. Other apps, allow clinicians to monitor a patient's bowel and bladder health, as well as those with rheumatoid arthritis. These apps are already in use at multiple NHS Trusts and clinics. Funds are being raised to complete development of their apps to help those with lupus and lung cancer, in addition to further developing their existing products. The company aims to have thousands of apps that will be available worldwide to provide self-service treatment at any time. Living With is expecting to earn £1.07m in revenue by the end of March 2019.
investment: £103,000 target: £350,000
status: Active 4 days
to go
More Information
29%
Course Match Technology EIS
Course Match is a mobile application software designed to collate information on educational universities and courses. Course Match's mission is to help the students discover their perfect Uni course. With this application, students can explore, manage, and share by implementing a 'likes' system. Students can also discover opportunities for apprenticeship and connect with other students. With its proceeds, Course Match will sign up 60 institutions to Coursematch Connect in the next 18 months. It will also expand its team and drive the Course Match installs to more than 200,000.
investment: £180,000 target: £300,000
status: Active 37 days
to go
More Information
60%
Linear Diagnostics Medical EIS
Linear Diagnostics Limited (LDL) utilises a novel platform technology for assays in a wide range of sectors. With focus on simplicity, speed and sensitivity, LDL uses Linear Dichroism technology to develop a molecular diagnostic platform with the ability to detect multiple targets such as Chlamydia and Gonorrhoea, from a single sample in just 15 minutes. The platform is designed to offer diagnosis and treatment within a single clinical appointment. With the proceeds, this company will build a follow-on pipeline of POC products and explore the potential markers for head trauma.
investment: £61,000 target: £1,000,000
status: Active 3 days
to go
More Information
6%
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph